ENVELA CORP (ELA) Fundamental Analysis & Valuation

NYSEARCA:ELAUS29402E1029

Current stock price

17.75 USD
+0.67 (+3.92%)
At close:
17.75 USD
0 (0%)
After Hours:

This ELA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ELA Profitability Analysis

1.1 Basic Checks

  • ELA had positive earnings in the past year.
  • ELA had a positive operating cash flow in the past year.
  • ELA had positive earnings in 4 of the past 5 years.
  • ELA had a positive operating cash flow in 4 of the past 5 years.
ELA Yearly Net Income VS EBIT VS OCF VS FCFELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

  • With an excellent Return On Assets value of 11.22%, ELA belongs to the best of the industry, outperforming 86.29% of the companies in the same industry.
  • ELA has a Return On Equity of 16.71%. This is in the better half of the industry: ELA outperforms 78.23% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.27%, ELA belongs to the top of the industry, outperforming 83.06% of the companies in the same industry.
  • ELA had an Average Return On Invested Capital over the past 3 years of 12.62%. This is in line with the industry average of 13.35%.
Industry RankSector Rank
ROA 11.22%
ROE 16.71%
ROIC 12.27%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ELA Yearly ROA, ROE, ROICELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • ELA has a better Profit Margin (4.89%) than 77.42% of its industry peers.
  • In the last couple of years the Profit Margin of ELA has grown nicely.
  • The Operating Margin of ELA (5.97%) is better than 73.39% of its industry peers.
  • ELA's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 23.25%, ELA is doing worse than 72.58% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ELA has grown nicely.
Industry RankSector Rank
OM 5.97%
PM (TTM) 4.89%
GM 23.25%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
ELA Yearly Profit, Operating, Gross MarginsELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

8

2. ELA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELA is creating some value.
  • ELA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ELA Yearly Shares OutstandingELA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ELA Yearly Total Debt VS Total AssetsELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 12.68 indicates that ELA is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 12.68, ELA belongs to the top of the industry, outperforming 97.58% of the companies in the same industry.
  • The Debt to FCF ratio of ELA is 1.51, which is an excellent value as it means it would take ELA, only 1.51 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 1.51, ELA is doing good in the industry, outperforming 79.03% of the companies in the same industry.
  • A Debt/Equity ratio of 0.16 indicates that ELA is not too dependend on debt financing.
  • ELA has a better Debt to Equity ratio (0.16) than 64.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.51
Altman-Z 12.68
ROIC/WACC1.4
WACC8.77%
ELA Yearly LT Debt VS Equity VS FCFELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

  • ELA has a Current Ratio of 5.19. This indicates that ELA is financially healthy and has no problem in meeting its short term obligations.
  • ELA has a better Current ratio (5.19) than 97.58% of its industry peers.
  • A Quick Ratio of 2.65 indicates that ELA has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.65, ELA belongs to the best of the industry, outperforming 92.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.19
Quick Ratio 2.65
ELA Yearly Current Assets VS Current LiabilitesELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. ELA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 128.00% over the past year.
EPS 1Y (TTM)128%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%283.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%66.59%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.09% on average over the next years.
  • Based on estimates for the next years, ELA will show a quite strong growth in Revenue. The Revenue will grow by 15.05% on average per year.
EPS Next Y-26.38%
EPS Next 2Y-3.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.02%
Revenue Next 2Y15.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ELA Yearly Revenue VS EstimatesELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
ELA Yearly EPS VS EstimatesELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

2

4. ELA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 31.14, which means the current valuation is very expensive for ELA.
  • ELA's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, ELA is valued at the same level.
  • ELA is valuated quite expensively with a Price/Forward Earnings ratio of 42.30.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ELA is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 23.69. ELA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 31.14
Fwd PE 42.3
ELA Price Earnings VS Forward Price EarningsELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • ELA's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as ELA.
Industry RankSector Rank
P/FCF 55.66
EV/EBITDA 30.23
ELA Per share dataELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The decent profitability rating of ELA may justify a higher PE ratio.
  • ELA's earnings are expected to decrease with -3.09% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.09%
EPS Next 3YN/A

0

5. ELA Dividend Analysis

5.1 Amount

  • ELA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ELA Fundamentals: All Metrics, Ratios and Statistics

ENVELA CORP

NYSEARCA:ELA (4/9/2026, 4:15:00 PM)

After market: 17.75 0 (0%)

17.75

+0.67 (+3.92%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-18
Earnings (Next)05-05
Inst Owners18.06%
Inst Owner Change-0.47%
Ins Owners49.49%
Ins Owner Change0.04%
Market Cap460.79M
Revenue(TTM)N/A
Net Income(TTM)10.20M
Analysts80
Price Target16.83 (-5.18%)
Short Float %2.35%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.33%
Min EPS beat(2)67.56%
Max EPS beat(2)101.11%
EPS beat(4)4
Avg EPS beat(4)57.23%
Min EPS beat(4)18.81%
Max EPS beat(4)101.11%
EPS beat(8)7
Avg EPS beat(8)35.99%
EPS beat(12)9
Avg EPS beat(12)35.83%
EPS beat(16)12
Avg EPS beat(16)32.71%
Revenue beat(2)2
Avg Revenue beat(2)16.02%
Min Revenue beat(2)15.99%
Max Revenue beat(2)16.06%
Revenue beat(4)4
Avg Revenue beat(4)12.98%
Min Revenue beat(4)2.14%
Max Revenue beat(4)17.74%
Revenue beat(8)7
Avg Revenue beat(8)11.04%
Revenue beat(12)9
Avg Revenue beat(12)5.98%
Revenue beat(16)13
Avg Revenue beat(16)9.26%
PT rev (1m)26.92%
PT rev (3m)26.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 31.14
Fwd PE 42.3
P/S 2.21
P/FCF 55.66
P/OCF 46.7
P/B 7.55
P/tB 8.56
EV/EBITDA 30.23
EPS(TTM)0.57
EY3.21%
EPS(NY)0.42
Fwd EY2.36%
FCF(TTM)0.32
FCFY1.8%
OCF(TTM)0.38
OCFY2.14%
SpS8.04
BVpS2.35
TBVpS2.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.49
Profitability
Industry RankSector Rank
ROA 11.22%
ROE 16.71%
ROCE 15.68%
ROIC 12.27%
ROICexc 17.71%
ROICexgc 20.38%
OM 5.97%
PM (TTM) 4.89%
GM 23.25%
FCFM 3.96%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ROICexc(3y)17.69%
ROICexc(5y)18.43%
ROICexgc(3y)21.62%
ROICexgc(5y)22.7%
ROCE(3y)16.14%
ROCE(5y)17.45%
ROICexgc growth 3Y-9.57%
ROICexgc growth 5Y-0.97%
ROICexc growth 3Y-7.64%
ROICexc growth 5Y1.09%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
F-Score7
Asset Turnover2.3
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.51
Debt/EBITDA 0.67
Cap/Depr 87.8%
Cap/Sales 0.76%
Interest Coverage 32.03
Cash Conversion 69.13%
Profit Quality 81.14%
Current Ratio 5.19
Quick Ratio 2.65
Altman-Z 12.68
F-Score7
WACC8.77%
ROIC/WACC1.4
Cap/Depr(3y)141.77%
Cap/Depr(5y)313.83%
Cap/Sales(3y)1.17%
Cap/Sales(5y)2.18%
Profit Quality(3y)69.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%283.33%
EPS Next Y-26.38%
EPS Next 2Y-3.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%66.59%
Revenue Next Year8.02%
Revenue Next 2Y15.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y58.53%
EBIT growth 3Y-4.94%
EBIT growth 5Y20.28%
EBIT Next Year89.14%
EBIT Next 3Y35.84%
EBIT Next 5YN/A
FCF growth 1Y99.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.16%
OCF growth 3Y53.73%
OCF growth 5YN/A

ENVELA CORP / ELA Fundamental Analysis FAQ

What is the fundamental rating for ELA stock?

ChartMill assigns a fundamental rating of 5 / 10 to ELA.


Can you provide the valuation status for ENVELA CORP?

ChartMill assigns a valuation rating of 2 / 10 to ENVELA CORP (ELA). This can be considered as Overvalued.


How profitable is ENVELA CORP (ELA) stock?

ENVELA CORP (ELA) has a profitability rating of 7 / 10.


What are the PE and PB ratios of ENVELA CORP (ELA) stock?

The Price/Earnings (PE) ratio for ENVELA CORP (ELA) is 31.14 and the Price/Book (PB) ratio is 7.55.


How financially healthy is ENVELA CORP?

The financial health rating of ENVELA CORP (ELA) is 8 / 10.